BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 28669830)

  • 1. Drivers and impact of antifungal therapy in critically ill patients with Aspergillus-positive respiratory tract cultures.
    Paiva JA; Mergulhão P; Gomes A; Taccone FS; Van den Abeele AM; Bulpa P; Misset B; Meersseman W; Dimopoulos G; Rello J; Vogelaers D; Blot S
    Int J Antimicrob Agents; 2017 Oct; 50(4):529-535. PubMed ID: 28669830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Invasive pulmonary aspergillosis is associated with adverse clinical outcomes in critically ill patients receiving veno-venous extracorporeal membrane oxygenation.
    Rodriguez-Goncer I; Thomas S; Foden P; Richardson MD; Ashworth A; Barker J; Geraghty CG; Muldoon EG; Felton TW
    Eur J Clin Microbiol Infect Dis; 2018 Jul; 37(7):1251-1257. PubMed ID: 29623451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Invasive pulmonary aspergillosis due to azole-resistant Aspergillus lentulus.
    Tetsuka N; Yaguchi T; Machida H; Ito S; Miyairi I
    Pediatr Int; 2017 Mar; 59(3):362-363. PubMed ID: 28317305
    [No Abstract]   [Full Text] [Related]  

  • 4. Invasive pulmonary aspergillosis in patients with solid tumours: risk factors and predictors of clinical outcomes.
    Dandachi D; Wilson Dib R; Fernández-Cruz A; Jiang Y; Chaftari AM; Hachem R; Raad I
    Ann Med; 2018 Dec; 50(8):713-720. PubMed ID: 30230385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Invasive pulmonary aspergillosis in critically ill patients with hematological malignancies.
    Pardo E; Lemiale V; Mokart D; Stoclin A; Moreau AS; Kerhuel L; Calvet L; Valade S; De Jong A; Darmon M; Azoulay E
    Intensive Care Med; 2019 Dec; 45(12):1732-1741. PubMed ID: 31599334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Putative invasive pulmonary aspergillosis in critically ill patients with chronic obstructive pulmonary disease: a matched cohort study.
    Delsuc C; Cottereau A; Frealle E; Bienvenu AL; Dessein R; Jarraud S; Dumitrescu O; Le Maréchal M; Wallet F; Friggeri A; Argaud L; Rimmelé T; Nseir S; Ader F
    Crit Care; 2015 Dec; 19():421. PubMed ID: 26631029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significance of Aspergillus spp. isolation from lower respiratory tract samples for the diagnosis and prognosis of invasive pulmonary aspergillosis in chronic obstructive pulmonary disease.
    He HY; Chang S; Ding L; Sun B; Li F; Zhan QY
    Chin Med J (Engl); 2012 Sep; 125(17):2973-8. PubMed ID: 22932166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Effectiveness of Culture-Directed Preemptive Anti-Aspergillus Treatment in Lung Transplant Recipients at One Year After Transplant.
    Hosseini-Moghaddam SM; Chaparro C; Luong ML; Azad S; Singer LG; Mazzulli T; Rotstein C; Keshavjee S; Husain S
    Transplantation; 2015 Nov; 99(11):2387-93. PubMed ID: 25961491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Real-world challenges and unmet needs in the diagnosis and treatment of suspected invasive pulmonary aspergillosis in patients with haematological diseases: An illustrative case study.
    Hoenigl M; Prattes J; Neumeister P; Wölfler A; Krause R
    Mycoses; 2018 Mar; 61(3):201-205. PubMed ID: 29112326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is Bulpa criteria suitable for the diagnosis of probable invasive pulmonary Aspergillosis in critically ill patients with chronic obstructive pulmonary disease? A comparative study with EORTC/ MSG and ICU criteria.
    Huang L; He H; Jin J; Zhan Q
    BMC Infect Dis; 2017 Mar; 17(1):209. PubMed ID: 28292284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical outcomes of lung-transplant recipients treated by voriconazole and caspofungin combination in aspergillosis.
    Thomas A; Korb V; Guillemain R; Caruba T; Boussaud V; Billaud E; Prognon P; Begué D; Sabatier B
    J Clin Pharm Ther; 2010 Feb; 35(1):49-53. PubMed ID: 20175811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Invasive mould infections in the ICU setting: complexities and solutions.
    Bassetti M; Bouza E
    J Antimicrob Chemother; 2017 Mar; 72(suppl_1):i39-i47. PubMed ID: 28355466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Approach to invasive pulmonary aspergillosis in critically ill patients.
    Koulenti D; Garnacho-Montero J; Blot S
    Curr Opin Infect Dis; 2014 Apr; 27(2):174-83. PubMed ID: 24514164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Invasive Pulmonary Aspergillosis.
    Ledoux MP; Guffroy B; Nivoix Y; Simand C; Herbrecht R
    Semin Respir Crit Care Med; 2020 Feb; 41(1):80-98. PubMed ID: 32000286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aspergillus in the lower respiratory tract of immunocompetent critically ill patients.
    Lugosi M; Alberti C; Zahar JR; Garrouste M; Lemiale V; Descorps-Desclère A; Ricard JD; Goldgran-Tolédano D; Cohen Y; Schwebel C; Vésin A; Timsit JF; Azoulay E
    J Infect; 2014 Sep; 69(3):284-92. PubMed ID: 24924557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebral aspergillosis in adult critically ill patients: a descriptive report of 10 patients from the AspICU cohort.
    Spapen H; Spapen J; Taccone FS; Meersseman W; Rello J; Dimopoulos G; Charles PE; Rao R; Pérez M; Martin C; Vogelaers D; Blot SI;
    Int J Antimicrob Agents; 2014 Feb; 43(2):165-9. PubMed ID: 24315314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intensive care medicine research agenda on invasive fungal infection in critically ill patients.
    Bassetti M; Garnacho-Montero J; Calandra T; Kullberg B; Dimopoulos G; Azoulay E; Chakrabarti A; Kett D; Leon C; Ostrosky-Zeichner L; Sanguinetti M; Timsit JF; Richardson MD; Shorr A; Cornely OA
    Intensive Care Med; 2017 Sep; 43(9):1225-1238. PubMed ID: 28255613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Invasive Pulmonary Aspergillosis in Nonimmunocompromised Hosts.
    Tudesq JJ; Peyrony O; Lemiale V; Azoulay E
    Semin Respir Crit Care Med; 2019 Aug; 40(4):540-547. PubMed ID: 31585479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The clinical significance of Aspergillus isolation from airway samples in critically ill patients].
    Shi Y; Liu HZ; Wang XT; Liu Y; Rui X; Tang B; Chai WZ; Zhao H
    Zhonghua Jie He He Hu Xi Za Zhi; 2009 Jun; 32(6):444-9. PubMed ID: 19957781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Value of consecutive galactomannan determinations for the diagnosis and prognosis of invasive pulmonary aspergillosis in critically ill chronic obstructive pulmonary disease.
    He H; Ding L; Chang S; Li F; Zhan Q
    Med Mycol; 2011 May; 49(4):345-51. PubMed ID: 20936913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.